Matt Carr: Cannabis Big Winner of 2020 Election

While the US presidential election result took some time to be determined, cannabis has been declared a big winner in the most recent American vote.

Matt Carr, chief trends strategist at the Oxford Club, spoke with the Investing News Network about the state of cannabis investment following a turbulent week of results from the race.

Joe Biden is now projected to become the next US president, defeating Donald Trump as the incumbent. Even though Biden hasn’t expressed full support for cannabis legalization, his running mate Kamala Harris has stood in favor of policy reform, which is expected to help the overall US cannabis industry.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Carr was speaking last Friday (November 6), before Biden’s victory was officially called by the media. While he wasn’t sure there would be an official election result anytime soon, he did feel the election already had a theme in place: cannabis.

Heading into the election last Tuesday (November 3), Carr — and the cannabis business community at large — was looking forward to the results for five state ballot measures that could legalize cannabis medically and recreationally. The five states voting were Arizona, Mississippi, Montana, New Jersey and South Dakota; in the end, all five measures cleared, representing more policy victories at the state level.

“That’s been great, that’s exactly what we wanted to see. Those five states have the opportunity to add as much as US$9 billion in new revenue between now and 2025,” Carr said.

Carr explained he was surprised to see stock market moves from Canadian cannabis companies given that these entities still can’t and won’t be able to tap into the US market in the near future.

“Those Canadian companies are really limited in their presence, but since those are the most actively traded because they trade on major US exchanges … those are where investors are turning for this kind of proxy on the results from those states,” he said.

In regards to the possibility of a sweeping federal legalization framework in the US under a Biden presidency, a move that could allow Canadian producers to enter into the gigantic market, Carr isn’t so sure it’ll be an immediate item for Biden and Harris to look into.

“I think you’re going to continue to make these inroads towards some change at the federal level; we already see at the state level that this is working,” Carr said. However, the expert said the success of the state markets makes him think the federal government may continue to leave policy up to individual states and allow for growth to come from that political movement.

Watch the video above to hear Carr’s full thoughts on the outlook for cannabis investments given the new US president. You can also click here for more cannabis videos on YouTube.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

THC-O-Acetate to be Produced Through Company’s Specialty Molecule Division

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), an extraction company that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids, is pleased to announce the launch of a Specialty Molecules Division to focus on the development and commercialization of novel psychoactive compounds. The division is supported by the Company’s existing intellectual property (“IP”) portfolio, including the manufacturing of CBD-O-acetate and the recently announced U.S. patent for the synthesis of THC-O-acetate.

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (the “Company”) is pleased to announce that it has completed construction of an industrial-grade distribution site and launched third party distribution services.

As part of its Phase 1 Construction project at the 196,000 square foot facility, the Company has built out 16,000 square feet of retail-ready product storage space, installed automated, assembly-line style packaging equipment for jar and pouch production, and built out a climate-controlled area that can store 30 tractor-trailer loads of cannabis and 230 pallets positions of -40 degree Fahrenheit freezers for storing live resin and live resin products. A secure loading bay and a small in-house fleet of refrigerated trucks is also in place.

Keep reading... Show less

Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) (“GWS” or the “Company”) is pleased to provide the following corporate update highlights on two portfolio clients KaleidoMyco LLC and Biominerales Pharma Corp. and announces the signing of the one-stop digital marketing team of North Equities Corp.

“With the talent, skills and resources we have at Global Wellness, we are well positioned to develop leading nutraceutical product portfolio brands focused on health and well-being. As hemp-extract and psilocybin is legalized in more jurisdictions such as Oregon where we already have a strong strategic relationship, we can then easily extend our existing product range, which will already have established routes to market and brand recognition, to include myco-dosing products. KaleidoMyco products will be in stores and on a consumer digital platform in the USA shortly and is currently being consumer tested in Europe as well. Our shareholders and customers are extremely important to us and we look forward to meeting the milestones we have outlined with the help of North Equities,” said Meris Kott, CEO.

Keep reading... Show less

VINIA(R)’s ability to increase dilation of arteries and to reduce blood vessel constriction allows it to fight the human aging process

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) announces that its flagship VINIA® product is the only dietary supplement available in the US market which has the capability for both reducing the endothelin 1 (ET1) enzyme as well as increasing the nitric oxide (NO) molecules, in order to increase the dilation of arteries and thereby improve blood flow. The presence of ET1 constricts the blood vessel, whereas the presence of NO dilates it. As a result of its “double-action” effect (proven by the Flow Mediated Dilatation (FMD) measurements in a double-blinded Placebo-controlled clinical trial*and in an in-vitro study** whose results were both published), VINIA® is uniquely positioned to combat the aging process caused by a reduction in blood flow.

Keep reading... Show less

Combined Company Highlights:

  • Experienced management team with a well-established brand portfolio
  • A highly sought after Colorado processing license in good standing
  • Bronnor adds one of the largest GMP-compliant cannabis processing and
    manufacturing facilities in Colorado
  • Distribution network of 1,200+ dispensaries across four states
  • Four high-profile THC and CBD brands

INDVR Brands, Inc. (CSE: IDVR) (the “Company” or “INDVR Brands” or “INDVR”), a premier cannabis brand house and edibles producer, is pleased to announce that it has completed the previously announced Asset Purchase Agreement (“APA”)of substantially all assets of Nevada based Strainz, Inc. and Colorado-based Bronnor, Corp. through its wholly owned subsidiary, INDVR Brands U.S., Inc, and the addition of Hugh Hempel as President & COO with a pending appointment to the Board of Directors at its next Annual Meeting of Shareholders on July 27, 2021.

Keep reading... Show less